Story perspectives

Healthcare Claims Under Scrutiny Amid Cancer Survival Advances

10/27/2025

43 3

Summary

Story summary

Christine Lovly of Vanderbilt-Ingram Cancer Center notes improvements in lung cancer survival over the past 20 years.
Emily Gee of the Center for American Progress criticizes CMS Administrator Mehmet Oz's claims about U.S. President Donald Trump’s healthcare plans as lacking substance.
Anna Dorothea Wagner expressed concerns over data interpretation in gastric cancer trials.
Praveena Gupta warned sensational headlines could cause public fear about GLP-1 research and legal blindness.

1 of 1

Story summary

Christine Lovly of Vanderbilt-Ingram Cancer Center notes improvements in lung cancer survival over the past 20 years.
Emily Gee of the Center for American Progress criticizes CMS Administrator Mehmet Oz's claims about U.S. President Donald Trump’s healthcare plans as lacking substance.
Anna Dorothea Wagner expressed concerns over data interpretation in gastric cancer trials.
Praveena Gupta warned sensational headlines could cause public fear about GLP-1 research and legal blindness.